Brian Murray

Brian Murray

CHIEF EXECUTIVE OFFICER

Mr. Murray established BV Murray & Co. Inc., a boutique investment bank in 1996 after 17 years at Bear Stearns in the corporate finance department where he was a Senior Managing Director. Prior to joining Bear Stearns in 1978, he was a partner at HC Wainwright & Co, an institutional Wall Street research firm. Over his career, Mr. Murray has obtained extensive worldwide experience in mergers and acquisitions, valuations and public and private debt and equity of offerings. Mr. Murray holds a B.S. degree in Economics from Villanova University, an MBA with honors (majoring in finance and international business) from the University of Chicago and is a Chartered Financial Analyst (“CFA”).

Suzy Couturier

Suzy Couturier

CHIEF OPERATING OFFICER

Suzy is a marketing strategist with extensive business management experience. She has developed and led successful teams for DuPont, Pfizer, Inamed and Allergan. Her 25-year career has been focused on building and reviving brand value for the professional and consumer segments in the health and beauty, cardiology and plastic surgery markets. Suzy successfully spearheaded the reintroduction of Allergan’s silicone breast implants in the US market. She actively participated in the development and launch of Project Beauty now Smart Beauty guide, ASAPS proprietary consumer website and The Plastic Surgery Channel theplasticsurgerychannel.com (plastic surgeons owned video based consumer website). She has also been invited to speak at ASAPS annual meeting in 2010 and 2011 on the importance of social media for plastic surgery practices. Suzy holds an MBA in Healthcare from St-Joseph’s University and a bachelor’s degree in chemistry from Laval University.

Mark S. Andrew

Mark S. Andrew, MD

CO-FOUNDER AND CHIEF SCIENTIFIC OFFICER (CSO)

Dr Andrew is the Founder and Chief Scientific Officer of Medality Medical, LLC. He is the co-inventor of Tissue Liquefaction Technology® (TLT). Medality Medical’s’ HydraSolve® is the second clinical application of TLT, the first being the AquaLase® Liquefaction Device, a small-incision cataract removal technology on Alcon’s premier cataract machine, the INFINITI® Vision System, used routinely in more than 50 countries. Dr Andrew, a Fellow of the American Academy of Ophthalmology, is a board-certified ophthalmologist with more than 25 years’ experience. He received his medical degree from Jefferson Medical College (Sidney Kimmel Medical College) in Philadelphia, PA, and served his residency at Hahnemann University Hospital in Philadelphia. His scientific background includes basic science research in biochemistry, endocrinology, and immunology, as well as research in fluid dynamics at: the National Eye Institute of the National Institutes of Health (NIH), Drexel University School of Biomedical Engineering, Jefferson Medical College (Sidney Kimmel Medical College), Wills Eye Hospital and the Penn State Health Milton S. Hershey Medical Center. Dr Andrew holds 10 issued US patents, 27 issued foreign patents, with more pending. Dr. Andrew’s inventions have led to 6 FDA clearances, 25 peer-reviewed journal articles and numerous surgical textbook citations.